Welcome.
There are very few similarities between the failed Exubera and Afrezza. The one thing they share is the point of entry- the lungs. Pharmakinetics, onset of action and the amount of time spent in the body all favor Afrezza in a major way.
Let this product be approved and we will see how many patients immediately want access to the benefits.